A growing number of Americans are becoming patients, and many are diagnosed too late
Our Solution: Detecting Early
A cancer diagnosis can be scary. With Phylomics, it doesn't have to be. Our ability to easily and accurately detect cancer at its earliest stages makes cancer more affordable, treatable, and most importantly, survivable.
Looking for non-cell indicators of real-time changes in gene expression, immune activity, and proteins.
Intelligent model decomposes complex genomic, proteomic, and metabolomic datasets to reveal clinically actionable insights.
Our multidimensional tools show the relatedness between subgroups of healthy and diseased individuals and the latter's shared aberrations.
The significance of the proposed test that Phylomics is developing cannot be over-emphasized because it will radically reshape the field of medical oncology [...] Such a test will move the medical field beyond personalized medicine to precision medicine
Dr. Christopher Loffredo
Professor of Oncology and Program Leader for Cancer Prevention, Georgetown University
Working with the National Science Foundation has allowed us to take the first steps in moving our proprietary technology from the laboratory into the real world.